Intestinal Metaplasia Clinical Trials

5 recruiting

Intestinal Metaplasia Trials at a Glance

14 actively recruiting trials for intestinal metaplasia are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Xi'an, Cambridge, and Commack. Lead sponsors running intestinal metaplasia studies include Yongquan Shi, Chinese University of Hong Kong, and Instituto Portugues de Oncologia, Francisco Gentil, Porto.

Browse intestinal metaplasia trials by phase

Treatments under study

About Intestinal Metaplasia Clinical Trials

Looking for clinical trials for Intestinal Metaplasia? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Intestinal Metaplasia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Intestinal Metaplasia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting

Association Between Microplastic Exposure and the Pathological Progression of Gastric Carcinogenesis

Gastric CarcinomaIntestinal MetaplasiaGastritis Chronic+1 more
Yongquan Shi450 enrolled1 locationNCT07542652
Recruiting
Phase 2

REVerse Intestinal Metaplasia in the Stomach (REVISE)

Gastric Intestinal MetaplasiaGastric Precancer
Katherine Garman32 enrolled1 locationNCT06590454
Recruiting

A Study Collecting Health Information to Understand and Prevent Gastric Cancer

Gastric CancerGastric AdenocarcinomaDysplasia+2 more
Memorial Sloan Kettering Cancer Center3,200 enrolled7 locationsNCT06370143
Recruiting

The GAstric Precancerous Conditions Study

Gastric CancerHelicobacter Pylori InfectionAtrophic Gastritis+1 more
Stanford University600 enrolled1 locationNCT04191551
Recruiting
Phase 4

Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia

Gastric Intestinal Metaplasia
Yongquan Shi196 enrolled6 locationsNCT06610760
Recruiting

Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score

Artificial IntelligenceIntestinal Metaplasia of Gastric MucosaEndoscopy
Qilu Hospital of Shandong University3,000 enrolled3 locationsNCT07257796
Recruiting
Phase 4

Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia

Gastric Intestinal Metaplasia
Yongquan Shi400 enrolled1 locationNCT06610266
Recruiting

Intestinal Metaplasia Cohort for Gastric Cancer Prediction

Intestinal Metaplasia of Gastric Mucosa
Seoul National University Hospital1,000 enrolled1 locationNCT06075199
Recruiting

Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study

Atrophic GastritisHelicobacter PyloriIntestinal Metaplasia
Chinese University of Hong Kong260 enrolled2 locationsNCT05053945
Recruiting

Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis

Gastric CancerAtrophic GastritisIntestinal Metaplasia
Chinese University of Hong Kong1,300 enrolled1 locationNCT04840056
Recruiting

Cytosponge for Gastric Intestinal Metaplasia

Gastric CancerGastric Intestinal MetaplasiaGastric Atrophy
University of Cambridge226 enrolled1 locationNCT05657080
Recruiting
Not Applicable

The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE

Intestinal MetaplasiaBarrett's Esophagus
E-DA Hospital165 enrolled1 locationNCT05818072
Recruiting
Not Applicable

SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up

Gastric CancerAtrophic GastritisGastric Dysplasia+1 more
Instituto Portugues de Oncologia, Francisco Gentil, Porto912 enrolled1 locationNCT04613570
Recruiting

Surveillance of Patients With Precancerous Lesions of the Stomach

Gastric CancerGastric DysplasiaGastric Intestinal Metaplasia+1 more
University of Latvia2,000 enrolled1 locationNCT03250091